search close
Reporter : Kim Yoo-chul
Sun, January 29, 2023 | 11:35
ST Pharm in talks with Moderna over contract manufacturing of COVID-19 vaccine
Korean biotechnology firm, ST Pharm, is in talks with Moderna to produce messenger RNA (mRNA) COVID-19 vaccines, sources familiar with the issue told The Korea Times, Tuesday. “ST Pharm is in talks with Moderna to produce its mRNA vaccines following approval by the Ministry of Food and Drug Safety,” one source said on condition of anonymity.
[EXCLUSIVE] LGES seeks to raise $8 bil. through IPO in Q4
LG Energy Solution (LGES), the world's top-tier battery manufacturer, plans to list its shares on the domestic stock exchange in the fourth quarter of this year to raise as much as $8 billion, a source familiar with the issue told The Korea Times, Monday. “LGES plans to push for an initial public offering (IPO) in the fourth quarter of this year at the earliest. It internally...
Ohio, Texas emerge as candidates for SK-Ford battery joint venture
Two U.S. states - Ohio and Texas - are emerging as the candidates to house SK Innovation's (SKI) battery joint venture with Ford Motor, with Ohio gaining a slight edge over Texas, two sources told The Korea Times, Sunday.
LG gives awards to doctor and domestic worker for contributions to community
LG Foundation has granted its humanitarian awards to Ko Young-cho, for providing free medical services to people in need for 48 years, and to domestic worker Noh Pan-soon, for donating her life savings to underprivileged members of her local community.
LG wins recognition from Jaguar Land Rover
LG Innotek, LG Group's components affiliate, has been recognized by Jaguar Land Rover for the quality of a component it sells to the high-end automaker.
[EXCLUSIVE] SK eyeing acquisition of parts suppliers in Japan
SK Group, one of Korea's top business conglomerates, is eyeing the acquisition of component and parts suppliers in Japan, according to sources directly involved with the issue, Tuesday.
Samsung set to sign vaccine deal with Moderna
Samsung Biologics is set to agree with Moderna under with the Samsung Group's biotechnology affiliate to manufacture the latter's messenger RNA (mRNA)-based COVID vaccines at its plant in South Korea, according a high-ranking government official, Friday.
Samsung, SK to scale up US investments
As U.S. President Joe Biden seemingly regards South Korea as a possible weak link in Washington's confrontational stance toward China, Cheong Wa Dae and the country's trade ministry are asking leading conglomerates to invest more in the United States.
Korea remains confident about receiving Moderna, Pfizer vaccines
A day after U.S. President Joe Biden said his administration plans to send an additional 20 million doses of COVID-19 vaccines abroad by the end of June, a senior Korean government official said the United States will send a “substantial amount of vaccines” to South Korea.
[ANALYSIS] SK hynix unlikely to acquire GlobalFoundries
After its chief executive Park Jung-ho clarified that SK hynix plans to double the capacity of its foundry (contract-based chip fabrication), investors have been saying that the world's No. 2 memory chipmaker will “soon” try to invest in a foundry chip-making company.